These findings are consistent with previous studies that have reported a beneficial association between the rs766432 polymorphism and laboratory markers in SCD, reinforcing its role as a polymorphism presence and improved hematological indices does not necessarily suggest a distinct role for BCL11A. This evidence concerns the gene BCL11A and Schnyder corneal dystrophy.